e-learning
resources
Vienna 2003
Monday 29.09.2003
Assessment and pathological processes of lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Guiding atropine treatment only by monitoring bronchial secretion - a good attitude in organophosphorates (OP) poisons?
O. R. Petris, F. Gradinariu (Iasi, Romania)
Source:
Annual Congress 2003 - Assessment and pathological processes of lung injury
Session:
Assessment and pathological processes of lung injury
Session type:
Thematic Poster Session
Number:
1743
Disease area:
Airway diseases, Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. R. Petris, F. Gradinariu (Iasi, Romania). Guiding atropine treatment only by monitoring bronchial secretion - a good attitude in organophosphorates (OP) poisons?. Eur Respir J 2003; 22: Suppl. 45, 1743
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The role of adherence to inhaled corticosteroids (ICS) in the relationship between blood eosinophilia and asthma control
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Combined inhaled corticosteroid and long acting β agonist treatment of paediatric asthma: experience of an asthma care programme
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009
Optimal adherence with inhaled corticosteroids is related to better health status
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
First in class, respiratory drug gas & drug vapor delivered in a revolutionary and new portable device
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Patients’ opinion for their inhalation device. An assessment of convenience and use
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Why are specific inhalation challenges (SIC) negative in workers with suspected occupational asthma?
Source: International Congress 2019 – Occupational lung diseases: from diagnostic techniques to classical and novel causes
Year: 2019
Protocol of early mobilization and rehabilitation in critical patients using inotropic medications: Is it really safe? Our hands on practice!
Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases
Year: 2019
Tracheostomized (TCS) patients: Is it possible to manage noninvasively tracheobronchial secretions?
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015
Therapeutic approaches beyond positive airway pressure and bronchodilators: time for rehabilitation?
Source: Sleep and Breathing Conference 2021
Year: 2021
Establishment and evaluation of a new measurement of cough reflex sensitivity: Cough provocation by agonist of TRPA1 (cinnamaldehyde)
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014
Biopharmaceutical and chemical compatibility of the combination of salbutamol hemisuccinate and methatropium iodide
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Novel jet nebulizer/holding chamber for drug delivery to the deep lung
Source: International Congress 2016 – Pulmonary drug delivery
Year: 2016
The pef monitoring in asthma: what the compliance is dependent upon?
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
In whom should regular asthma controller therapy be initiated?
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Critical steps: An evaluation of critical handling errors with DPI use in Greece
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test?
Source: Eur Respir J, 55 (2) 1902112; 10.1183/13993003.02112-2019
Year: 2020
Induced sputum cytology and pulmonary function tests in ex-smoker asthmatic patients controlled with inhaled steroid and long acting beta agonist therapy
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Inhalation technique education in asthma or COPD: The value of a visual instruction card
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Added value of electronic monitoring in the assessment of asthma control?
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
Quality of life in patients with bronchial asthma: impact of regular monitoring and good compliance
Source: Eur Respir J 2004; 24: Suppl. 48, 285s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept